Company Long-Term Loans and Borrowings: agapeatpgroup.com (ATPC)

Public company logo of Agape ATP (ATPC)

This price chart for Agape ATP Corporation (ATPC) reflects the expansion of personalized healthcare and diagnostics in Asia, where long-term debt stands at 0.00. The holding company's prosperity relies on the influx of new clients and the implementation of comprehensive wellness systems. Meanwhile, the business is pursuing a path of organic growth through local alliances, completely eschewing mergers and acquisitions.

ATPC Agape ATP Corp Company Long-Term Debts (02/21/2024 - 10/31/2026)

Summary analytical data breakdowns for Agape ATP (ATPC)

- market price and analyst price targets:
Stock Price Agape ATP Corp|ATPC - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Agape ATP|ATPC - Total Company Value
- book capitalization information:
Accounting Value per Share Agape ATP|ATPC - Book Capitalization|Market Capitalization to Book Value Ratio agapeatpgroup.com|ATPC - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Agape ATP Corporation|ATPC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Agape ATP Corp|ATPC - Company Aggregate Debts|Debts to Book Value Agape ATP|ATPC - Company Long-Term Liabilities|Amount of Current Liabilities Agape ATP|Quick Ratio agapeatpgroup.com
- earnings and multiples data:
ATPC - Net Profit
Summary company analytics:Agape ATP Corporation
Brand item of Agape ATP Corp.

The stability of the preventive medicine niche and Agape ATP Corporation (ATPC) investments in qualified personnel necessitate precise capital management. This metric aggregates all credit obligations with maturities exceeding one year, enabling an assessment of liability servicing costs and financial stability, which is clearly reflected in the trajectory of the corporation's long-term loans and borrowings during periods of Fed rate volatility.

Competitor analysis for Agape ATP Corporation

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|89bio, Inc. - Company Long-Term Debts|Long-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Long-Term Liabilities|MDXG: Amount of Long-Term Liabilities|RZLT (Rezolute Corp) - Company Long-Term Debts|Company Long-Term Debts Lexicon Corp|Company Long-Term Debts MBX|Company Long-Term Debt ALT (altimmune.com)|Company Long-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Long-Term Debt|BIOA - Company Long-Term Debt|BMEA: Company Long-Term Debt|QNCX: Company Long-Term Debts|GUTS - Long-Term Debt Volume|Company Long-Term Debt vTv Therapeutics, Inc.|Pluri Inc (PLUR) - Long-Term Debt Volume|Company Long-Term Debt Synlogic, Inc. (SYBX)|Company Long-Term Liabilities Lipocine Corporation LPCN|Company Long-Term Debts MTNB (Matinas BioPharma Holdings)|Company Long-Term Debts Spruce Biosciences Inc. SPRB|Galecto - Company Long-Term Debts|Long-Term Indebtedness Carmell Corp. (CTCX)|LUMO: Company Long-Term Debts|Organovo Corp (ONVO) - Company Long-Term Debts|Company Long-Term Debt Radius Recycling, Inc.